按產品類型、應用和地區分類的骨移植和骨替代材料市場

Bone Graft and Substitutes Market, By Product Type, By Application, By Geography

出版日期: 2026年01月21日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，骨移植和骨替代材料市場價值將達到 44 億美元，預計到 2033 年將達到 66 億美元，2026 年至 2033 年的複合年成長率為 6.9%。

報告覆蓋範圍		報告詳情
基準年：	2025	2026年市場規模：	44億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	6.90%	2033 年的預測值：	66億美元

骨移植整合是指供體骨組織與受體體內新沉積骨組織之間的相互嵌合與包裹過程。它是一種用途廣泛的技術，利用自然機制取代缺失的骨組織並促進骨骼生長。自體骨移植是最成功的骨移植方法，被認為是骨替代的黃金標準。骨移植用途廣泛，包括填充囊腫或腫瘤造成的空腔，以及促進初次治療後未癒合的骨折癒合。

市場動態

根據《材料科學與醫學材料雜誌》（2014）的報告，骨移植是繼輸血之後全球第二常用的組織移植技術。該雜誌2014年的統計數據顯示，每年進行超過200萬例骨移植手術，光在美國就進行了超過50萬例骨移植植入手術。這主要歸功於新型器械的易用性和操作性、更高的安全性、更短的手術時間、更低的術中成本以及對各種臨床挑戰的適應性。

全球骨移植和骨替代材料市場預計在預測期內將顯著成長，因為製造商正採用新技術開發創新移植骨替代物。這包括推出新型生長因子增強型移植材料，以提高術後恢復的移植品質。例如，2015年，私人公司Therapedics, Inc.的胜肽增強型移植材料「i-Factor」獲得美國FDA核准，用於頸切除術和融合手術。此移植材料基於小分子胜肽（P-15）技術，可透過細胞黏附和活化來促進骨骼生長。

本次調查的主要特點

本報告以 2018 年為基準年，對 2019 年至 2027 年的全球骨移植和骨替代市場進行了詳細分析。
我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新技術發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數對全球骨移植和骨替代市場的主要企業進行了分析：公司概況、財務表現、技術組合、地理分佈、分銷策略、關鍵發展和策略。
本報告的研究結果將使企業負責人和經營團隊能夠就未來的技術投資、政府政策、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球骨移植和骨替代市場報告將為該市場中的各種相關人員提供有價值的資訊，包括投資者、技術製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第7章競爭情勢

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- Ace Surgical Supply Co., Inc.
- Exactech, Inc.
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- BioHorizons Implant Systems, Inc.
- Globus Medical, Inc.
- RTI Surgical, Inc.
- Geistlich Pharma
- Megagen
- Novadip Biosciences
- Mesoblast Ltd.
- Alphatec Spine, Inc.
- Institut Straumann AG
- NuVasive, Inc.
- OsteoMed LLC
- KYERON Medical Innovations
- ORTHOFIX INTERNATIONAL NV
- Johnson &Johnson
- Bone Therapeutics SA
- K2M Group Holdings, Inc.
- OsteoNovus

第8章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第9章各節

參考
調查方法

簡介目錄

Product Code: CMI1050

Bone Graft And Substitutes Market is estimated to be valued at USD 4.40 Bn in 2026 and is expected to reach USD 6.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.90%	2033 Value Projection:	USD 6.6 Bn

The incorporation of a bone graft can be defined as a procedure of interdigitation and envelopment of the donor bone tissue with the new bone deposited by the recipient. It is a versatile that replaces the lost bone tissue, enhances bone growth using natural mechanisms. The natural bone graft are the most successful types of bone grafts and are considered to be the gold standard for replacement of missing bones. Bone grafts are in used in various purposes such as to fill the cavities resulting from cysts, tumors, or other causes, to stimulate the healing of fractures that have failed to heal after an initial treatment attempt, and others.

Market Dynamics

According to the Journal of Materials Science and Materials in Medicine, 2014, bone grafting frequency is the second most frequent tissue transplantation technique carried out globally after blood transfusion. The 2014 statistics reported in the Journal of Materials Science and Materials in Medicine, states that over 2 million bone grafting procedures are performed annually with over 500,000 graft implant procedures carried out in the U.S. itself. This is attributed to the ease of use and handling of new devices, improved safety profile, time advantages, intraoperative costs as well as the adaptability to a variety of clinical challenges.

The global bone graft, substitutes and membrane market is expected to witness a significant growth over the forecast period, owing to adoption of new technologies by manufacturers for development of innovative and novel bone graft substitutes. This includes the launches of novel growth factor enhanced grafts that improves the quality of grafts in terms of post-surgical recovery. For instance, in 2015, Cerapedics, a privately owned orthobiologics company received the U.S. FDA approval for i-Factor, which is a peptide enhanced graft that is used in cervical discectomy and fusion. The graft was based on small peptide (P-15) technology that helps in supporting bone growth through cell attachment and activation

Key features of the study

This report provides in-depth analysis of the global bone graft and substitutes market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019-2027), considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global bone graft and substitutes market based on the following parameters - company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Ace Surgical Supply Co., Inc., NovaBone Product, LLC., Exactech, Inc., Medtronic Plc., LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation., BioHorizons Implant Systems, Inc., Globus Medical, Inc., RTI Surgical, Inc., Geistlich Pharma, Megagen, Novadip Biosciences, Mesoblast Ltd., Alphatec Spine, Inc., Institut Straumann AG, NuVasive, Inc., OsteoMed LLC, KYERON Medical Innovations, ORTHOFIX INTERNATIONAL N.V., Johnson & Johnson, Bone Therapeutics SA, K2M Group Holdings, Inc., and OsteoNovus
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global bone graft and substitutes market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global bone graft and substitutes market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

By Product Type
- Bone Grafts
- Allografts
- Xenografts
- Bone Graft Substitutes
- Ceramics
- Composites
- Polymers
- Demineralized Bone Matrix
- Bone Morphogenetic Proteins
- Others
By Application
- Spinal Fusion
- Dental Bone Grafts
- Craniomaxillofacial
- Joint Reconstruction
- Trauma & Extremities
- Oncology
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Ace Surgical Supply Co., Inc.
- NovaBone Product, LLC.
- Exactech, Inc.
- Medtronic Plc.
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation.
- BioHorizons Implant Systems, Inc.
- Globus Medical, Inc.
- RTI Surgical, Inc.
- Geistlich Pharma
- Megagen
- Novadip Biosciences
- Mesoblast Ltd.
- Alphatec Spine, Inc.
- Institut Straumann AG
- NuVasive, Inc.
- OsteoMed LLC
- KYERON Medical Innovations
- ORTHOFIX INTERNATIONAL N.V.
- Johnson & Johnson
- Bone Therapeutics SA
- K2M Group Holdings, Inc.
- OsteoNovus

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Bone Graft And Substitutes Market, By Product Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bone Grafts
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Allografts
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Xenografts
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bone Graft Substitutes
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Ceramics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Composites
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Polymers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Demineralized Bone Matrix
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bone Morphogenetic Proteins
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Bone Graft And Substitutes Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Spinal Fusion
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dental Bone Graft
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Craniomaxillofacial
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Joint Reconstruction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Trauma & Extremities
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Bone Graft And Substitutes Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Ace Surgical Supply Co., Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
  - NovaBone Product, LLC.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Exactech, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
  - Medtronic Plc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- LifeNet Health
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Zimmer Biomet Holdings, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Stryker Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- BioHorizons Implant Systems, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Globus Medical, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- RTI Surgical, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Geistlich Pharma
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Megagen
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novadip Biosciences
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Mesoblast Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Alphatec Spine, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Institut Straumann AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- NuVasive, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- OsteoMed LLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- KYERON Medical Innovations
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- ORTHOFIX INTERNATIONAL N.V.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson & Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bone Therapeutics SA
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- K2M Group Holdings, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- OsteoNovus
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates